SCHEMBL22746699

SCHEMBL22746699

c1ccc(-c2ccc(-c3ccc(-n4c5ccc(-c6nc7ccccc7o6)cc5c5cc(-c6nc7ccccc7o6)ccc54)cc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.50
▸ ALDH1A1 P00352 7/20 0.50
▸ SMN1; SMN2 Q16637 7/20 0.50
▸ RAB9A P51151 6/20 0.50
▸ KDM4E B2RXH2 6/20 0.50
▸ HPGD P15428 6/20 0.50
▸ HSD17B10 Q99714 5/20 0.50
▸ HCRTR1 O43613 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ USP2 O75604 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ CASP3 P42574 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ SENP8 Q96LD8 1/20 0.50
▸ SENP7 Q9BQF6 1/20 0.50
▸ SENP6 Q9GZR1 1/20 0.50
▸ KMT2A Q03164 4/20 0.49
▸ TP53 P04637 4/20 0.49
▸ MEN1 O00255 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22746736 1.00 NPC1 (0.50) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E
SCHEMBL23108757 0.99 NPC1 (0.49) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E
SCHEMBL23108471 0.99 NPC1 (0.49) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E
SCHEMBL10065318 0.96 NPC1 (0.47) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E
SCHEMBL10065302 0.96 SMN1; SMN2 (0.51) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E
SCHEMBL23108423 0.96 NPC1 (0.51) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E
SCHEMBL10065292 0.96 NPC1 (0.51) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E
SCHEMBL10065144 0.96 NPC1 (0.51) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E
SCHEMBL10065301 0.96 SMN1; SMN2 (0.51) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E
SCHEMBL10065262 0.96 NPC1 (0.51) NPC1ALDH1A1SMN1; SMN2RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377492-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME P&H TECH CO., LTD 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377492-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME OCIAD1, OCIAD2, POU2F1 NPC1 622/4885ALDH1A1 582/4885SMN1; SMN2 4572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback